Healthcare
Innova Capital backs Ujastek Hospital
Innova Capital has invested in Poland-based Ujastek Obstetrics and Gynaecological Hospital.
Peppermint et al. invest in IOP
Peppermint Venture Partners, Enjoy Venture and KFW's ERP Startfonds have invested €1.6m in German eye disease monitoring company Implandata Ophthalmic Products (IOP), completing its series-A funding round.
Sovereign’s Christchurch Group makes acquisition
Sovereign Capital portfolio company Christchurch Group has acquired Woodlands Respite Care Centre from the MS Society.
I2C backs Keramat with €600,000
Government-backed Galician venture capital fund I2C has injected €600,000 into ceramic biomaterials firm Keramat.
Investor consortium sells Sirigen to BD
Seraphim Capital, Oxford Capital Partners, Nesta, IQ Capital and YFM Equity Partners have sold high sensitivity fluorescence manufacturer Sirigen Group Ltd to US trade player Becton Dickinson and Company (BD).
AXA PE acquires Riemser from TVM
AXA Private Equity has acquired a majority stake in German speciality pharmaceuticals company Riemser Arzneimittel from the company's founding family and minority investors, including TVM Capital.
Cinven acquires Mercury Pharma from HgCapital
Cinven has acquired UK-based speciality pharmaceutical company Mercury Pharma in a £465m secondary buyout from HgCapital.
Bridgepoint-backed Care UK makes acquisition
Bridgepoint-backed Care UK has acquired residential care provider Whitwood Care from family-owned Michael Wheatley Holdings.
Cherie Blair's PE fund raises £4.5m towards £75m target
Allele, a healthcare-focused private equity fund set up by Cherie Blair, is understood to have raised 6% of its £75m target.
Sovereign Capital's City & County makes ninth acquisition
Sovereign Capital-backed City & County Healthcare Group has acquired UK domiciliary care provider Help at Home, in a deal that marks the company's ninth bolt-on since 2009.
BC Partners buys Aenova from Bridgepoint
BC Partners has acquired German pharmaceutical manufacturer Aenova Group from Bridgepoint in a transaction understood to be valued at slightly less than €500m.
North West Fund backs Dot Medical
The North West Fund for Biomedical, managed by Spark Impact, has invested £550,000 in Dot Medical, which manufactures equipment to treat heart conditions.
Key Capital Partners backs £15m MBO of Nurse Plus
Key Capital Partners has backed the £15m MBO of UK-based healthcare staffing company Nurse Plus.
Azulis and Galia inject €15m into Bio-Clinic
Azulis Capital and Galia Gestion have invested a joint €15m in French medical analysis laboratory Bio-Clinic.
Are buyout firms well placed for healthcare reforms?
UK healthcare
Slovakia looking to take over Penta-backed Dôvera
Slovakian prime minister Robert Fico is mulling a takeover of two private health insurance companies, in a move that could threaten Penta's investment in Dôvera.
Cross acquires Micromacinazione
Swiss firm Cross Equity Partners has acquired a majority stake in Swiss micronisation technologies and services company Micromacinazione.
Imperial Innovations in £17m round for Cell Medica
Imperial Innovations Group has invested in a £17m funding round for its portfolio company Cell Medica.
Index et al. partially exit Funxional Therapeutics
Index Ventures, Novo A/S and Ventech have partially exited their investment in Funxional Therapeutics, following the company’s sale of its rights to lead anti-inflammatory drug FX 125L to German pharmaceuticals company Boehringer Ingelheim.
August Equity's Enara makes string of acquisitions
August Equity's portfolio company Enara, a British care provider, has completed four add-on acquisitions as part of its buy-and-build strategy.
Espiga sells Invesa to Animedica
Espiga Capital Gestión has sold Industrial Veterinaria (Invesa), a Spanish pharmaceutical products manufacturer for the veterinary industry, to German firm Animedica Group.
Mercapital makes €100m on Gasmedi sale
Mercapital has sold Spanish respiratory home therapies firm Gasmedi to French gas company Air Liquide for €330m.
Seventure leads €2m round for Domain Therapeutics
Seventure Partners has led a €2m financing round for biopharmaceutical firm Domain Therapeutics, contributing half of the fresh capital.